Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

San Diego, USA
3550 General Atomics Court
San Diego, CA, 92121
USA

People

President and Chief Executive Officer
Board of Directors
Director
Senior Vice President, Science & Technology

Funding

Tags

ViaCyte

ViaCyte formerly Novocell is a preclinical therapeutic company focused on diabetes. Their therapy is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in an encapsulation device. Data in their publications demonstrates that these cells can produce therapeutically relevant levels of insulin in response to blood glucose, and sustain diabetic animals. Their goal is a product which can free both Type 1 and Type 2 patients with diabetes from insulin dependence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications.

Recent Milestones

  • Dollar
    ViaCyte received $10.6M in Series C funding. (7/10/13)
    Posted 7/10/13 at 4:00am via pehub.com
  • Check
    ViaCyte — ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy (10/26/12)
    Posted 2/10/13 at 9:16pm via viacyte.com
  • Check
    ViaCyte added Steven R. Altman as Director. (1/1/12)
    Posted 9/11/13 at 8:28pm
  • Dollar
    ViaCyte received $25M in Series C funding. (7/16/07)
    Posted 10/19/13 at 3:35am via novocell.com
  • Dollar
    ViaCyte received $20M in Venture Round funding. (5/3/06)
    Posted 10/19/13 at 3:34am
  • Check
    ViaCyte added Allan Robins as Senior Vice President, Science & Technology.
    Posted 2/10/13 at 9:17pm
  • Check
    ViaCyte added Paul Laikind as President and Chief Executive Officer.
    Posted 6/18/12 at 2:16am

Videos

Screenshots

ViaCyte screenshot
Above: ViaCyte
Uploaded: 6/18/12

Sources

  1. EDGAR [edit]
  2. Novocell Raises $25 Million (novocell.com) [edit]
  3. ViaCyte Raises $10.6 Mln (pehub.com) [edit]
  4. ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy (viacyte.com) [edit]
Edit This Page
Last Edited 12/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy